President and CEO
David Thrower has over 20 years of experience at successful medical device companies, which have both significant professional and consumer market overlap.  Prior to joining BAROnova, David was President and CEO of Asante Solutions, a medical device company that developed and launched an innovative insulin pump for diabetes.  He served as CEO of InSound Medical, a manufacturer of a market-disruptive hearing aid system that was acquired by Sonova Holding AG.  David also held leadership roles with Align Technologies, manufacturer of Invisalign, clear aligners that straighten teeth as an alternative to braces; BioSource International; ReSound Medical; Quattro Consulting; and Bain & Company. David earned his undergraduate degree from Stanford University and his MBA from the Harvard Business School.


Vice President, Clinical Affairs & Regulatory Affairs
Dr. Cunningham brings with her a wealth of experience in leading clinical programs. 
Before joining BAROnova, Inc., she served as the Vice President of Clinical Affairs at Guided Delivery Systems, Inc., a structural heart medical device company developing a Class III cardiac implant. Prior to that, she held a variety of clinical leadership positions including Medical Director and Vice President of Clinical Affairs at TriReme Medical, Inc., and Medical Director and Vice President of Clinical Research and Education at VNUS Medical Technologies, Inc., (acquired by Covidien). She was also previously an 
assistant professor at Loyola University of Chicago and a practicing vascular surgeon 
in Shanghai, China.


Vice President, Research and Development

Kobi Iki has more than 20 years of experience in the medical-device industry directing research programs in oncology, cardiovascular, orthopedics and obesity. Before joining BAROnova, he served as the Vice President of Research for Leptos Biomedical, a company developing a neuromodulation therapy for obesity. Prior to that, Kobi held various management and senior executive positions of increasing responsibility at Miravant Medical Technologies, Corvascular, Oratec Interventions (acquired by Smith + Nephew Endoscopy), and Vascular Architects.  Kobi holds a Bachelor’s degree in Biological Sciences from UC Santa Barbara and a Masters in Physiology and Biophysics from Georgetown University.